CSIMarket Company Name, Ticker, Industry, else..
 
Lipella Pharmaceuticals Inc   (LIPO)
 

Lipella Pharmaceuticals Inc's Suppliers Performance

LIPO's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
LIPO Costs vs Sales of Suppliers Growth

• More on LIPO Suppliers






Lipella Pharmaceuticals Inc's Comment on Supply Chain


The company sources raw materials, including active pharmaceutical ingredients (APIs) and lipids, from multiple vendors who maintain a drug master file with the FDA. The raw material supply for LP-10 is obtained from these vendors. LP-10 is provided as a white, lyophilized powder composed of sphingomyelin phospholipids and tacrolimus. Each vial contains 80 mg of tacrolimus and sphingomyelin, with tacrolimus comprising 10% of the total weight. The powder is intended to be reconstituted with sterile water for injection prior to use. Quality control samples from each batch undergo release testing based on established product specifications, including assessments for identity and purity, residual solvent levels, sterility, and bacterial endotoxins.

Lipella Pharmaceuticals Inc's Comment on Supply Chain


The company sources raw materials, including active pharmaceutical ingredients (APIs) and lipids, from multiple vendors who maintain a drug master file with the FDA. The raw material supply for LP-10 is obtained from these vendors. LP-10 is provided as a white, lyophilized powder composed of sphingomyelin phospholipids and tacrolimus. Each vial contains 80 mg of tacrolimus and sphingomyelin, with tacrolimus comprising 10% of the total weight. The powder is intended to be reconstituted with sterile water for injection prior to use. Quality control samples from each batch undergo release testing based on established product specifications, including assessments for identity and purity, residual solvent levels, sterility, and bacterial endotoxins.







LIPO's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Lipella Pharmaceuticals Inc 0.00 0.47 -5.33 16
SUBTOTAL 0.00 0.00 0.00 -


Sources: Lipella Pharmaceuticals Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Lipella Pharmaceuticals Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.